What's Happening?
Dr. Sadhna Bokhiria, CEO of KIRIA Advisory Partners, has been accepted into the Forbes Business Council. This membership provides her with access to exclusive opportunities to collaborate with industry leaders and contribute expert insights to Forbes.com. Dr. Bokhiria has a decade-long experience in oncology, focusing on the psychosocial aspects of cancer care and their impact on patient outcomes. Her leadership at KIRIA Advisory Partners has driven the firm's expansion into the UK, Canada, and the EU, while also leading healthcare strategy in the U.S. The firm specializes in health-system decision intelligence and commercialization strategy, aiming to accelerate market progress and drive innovation in biopharma.
Why It's Important?
Dr. Bokhiria's inclusion in the Forbes Business Council highlights her influence in the healthcare industry, particularly in oncology and biopharma strategy. Her work at KIRIA Advisory Partners is significant for the U.S. healthcare system, as it provides strategic clarity to biopharma decision-makers, potentially improving patient outcomes and reducing uncertainty in healthcare delivery. The expansion of KIRIA Advisory Partners into international markets under her leadership suggests a growing influence in global healthcare strategy, which could lead to more integrated and innovative approaches to cancer care and biopharma commercialization.
What's Next?
Dr. Bokhiria plans to publish insights for biopharma leaders on various topics, including health-system decision intelligence and oncology commercialization. These publications will address market access and pricing strategies in the IRA era, as well as readiness for novel modalities. Her contributions to Forbes.com and collaboration with other council members may further enhance her impact on healthcare strategy, potentially influencing policy and practice in the U.S. and abroad.
Beyond the Headlines
Dr. Bokhiria's work in integrating laughter and intelligence into enterprise strategy reflects a unique approach to leadership and healthcare innovation. This gelotology aspect may offer new perspectives on improving patient care and organizational effectiveness, highlighting the importance of psychosocial factors in healthcare.
